|
NCK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56778999998997E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.68159999999996E-05 |
| Normal-vs-Stage2 |
2.892400E-01 |
| Normal-vs-Stage3 |
9.484100E-02 |
| Normal-vs-Stage4 |
3.720400E-01 |
| Stage1-vs-Stage2 |
3.065400E-01 |
| Stage1-vs-Stage3 |
4.826600E-01 |
| Stage1-vs-Stage4 |
2.562800E-03 |
| Stage2-vs-Stage3 |
6.845200E-01 |
| Stage2-vs-Stage4 |
2.210400E-01 |
| Stage3-vs-Stage4 |
5.447900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.33510000000093E-05 |
| Normal-vs-AfricanAmerican |
2.624700E-03 |
| Normal-vs-Asian |
9.533200E-01 |
| Caucasian-vs-AfricanAmerican |
4.852400E-01 |
| Caucasian-vs-Asian |
3.124200E-01 |
| AfricanAmerican-vs-Asian |
2.822600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.841590E-04 |
| Normal-vs-Female |
2.639200E-04 |
| Male-vs-Female |
1.565590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.759800E-01 |
| Normal-vs-Extreme_Weight |
6.901700E-03 |
| Normal-vs-Obese |
6.642200E-04 |
| Normal-vs-Extreme_Obese |
2.258600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.103000E-01 |
| Normal_Weight-vs-Obese |
7.380000E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.507000E-01 |
| Extreme_Weight-vs-Obese |
3.145400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.138000E-01 |
| Obese-vs-Extreme_Obese |
7.058600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.861600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.96539999947265E-07 |
| Normal-vs-Age(61-80Yrs) |
1.580430E-02 |
| Normal-vs-Age(81-100Yrs) |
5.386000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.263000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.093400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.995200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.819600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.292010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.838800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.73949990364986E-10 |
| Normal-VS-Type2 PRCC |
7.777200E-01 |
| Normal-VS-KIRP CIMP |
4.928000E-01 |
| Normal-VS-Unclassified PRCC |
7.507800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.7389000197623E-09 |
| Type1 PRCC-VS-KIRP CIMP |
7.106300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.276200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.865000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.428200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.508800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.033000E-01 |
| Normal-vs-N1 |
1.728760E-01 |
| Normal-vs-N2 |
3.652000E-01 |
| N0-vs-N1 |
7.563400E-01 |
| N0-vs-N2 |
9.888800E-01 |
| N1-vs-N2 |
8.616600E-01 |
|
|
